NCT06751498Recruiting
The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study
The Value of a Renal Artery Perfusion Model Based on Convolutional Neural Network in Predicting Renal Function After Partial Nephrectomy: A Prospective, Single-Center Study
Source: ClinicalTrials.gov · Last updated 17 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to develop a CNN-based machine module to predict postoperative fractional renal function in people who are proposed to undergo partial nephrectomy. The main question it aims to answer is: • Does this machine learning model accurately predict renal function after partial nephrectomy?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 25 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Apr 2027
- Lead sponsor
- Shao Pengfei
- Diseases
- Kidney cancer
- NCT number
- NCT06751498
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jan 2025 to the primary completion date, 1 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- people who receive preoperative molecular targeted therapy, immunotherapy, chemotherapy
- people with any contraindications to surgery
- people who convert to radical nephrectomy during surgery
- people who receive molecular targeted therapy, immunotherapy or chemotherapy during the postoperative follow-up period
Other illness
- people with serious systemic disease
Lab values
- people with Abnormal preoperative renal function, eGFR(estimated by CKD-EPI)\<90ml/min/1.73m2
Other
- people with surgically unresectable lesions
Who the study is looking for
- people with stage cT1 renal tumors confirmed by preoperative CT or MR
- people who are proposed to undergoing partial nephrectomy
- localized renal tumors without lymph node and distant metastases as defined by NCCN guidelines
- ECOG score of 0 or 1
- Life expectancy greater than 10 years
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.